The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of <i>PPAR</i>-<mml:math id="E1" xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi>γ</mml:mi></mml:math>

Unluturk, Ugur; Harmanci, Ayla; Kocaefe, Cetin; Yildiz, Bulent O.

doi:https://doi.org/10.1155/2007/49109

PPAR Research

On this page

Abstract References Copyright Related Articles

Review Article | Open Access

Volume 2007 | Article ID 049109 | https://doi.org/10.1155/2007/49109

The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-γ

Ugur Unluturk,¹Ayla Harmanci,^1,2Cetin Kocaefe,³and Bulent O. Yildiz^1,2

Academic Editor: Carolyn M. Komar

Received19 Jul 2006

Revised24 Nov 2006

Accepted03 Dec 2006

Published21 Feb 2007

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance. It is now well established that PCOS represents a complex trait similar to type-2 diabetes and obesity, and that both inherited and environmental factors contribute to the PCOS pathogenesis. A large number of functional candidate genes have been tested for association or linkage with PCOS phenotypes with more negative than positive findings. Lack of universally accepted diagnostic criteria, difficulties in the assignment of male phenotype, obscurity in the mode of inheritance, and particularly small sample size of the study populations appear to be major limitations for the genetic studies of PCOS. In the near future, utilizing the genome-wide scan approach and the HapMap project will provide a stronger potential for the genetic analysis of the syndrome.

References

R. Azziz, K. S. Woods, R. Reyna, T. J. Key, E. S. Knochenhauer, and B. O. Yildiz, “The prevalence and features of the polycystic ovary syndrome in an unselected population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2745–2749, 2004.
View at: Publisher Site | Google Scholar
J. K. Zawadzki and A. Dunaif, “Diagnostic criteria for polycystic ovary syndrome,” in Polycystic Ovary Syndrome, A. Dunaif, J. Givens, F. Haseltine, and G. R. Merriam, Eds., pp. 377–384, Blackwell Scientific, Boston, Mass, USA, 1992.
View at: Google Scholar
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Fertility and Sterility, vol. 81, no. 1, pp. 19–25, 2004.
View at: Publisher Site | Google Scholar
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, “Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome,” Human Reproduction, vol. 19, no. 1, pp. 41–47, 2004.
View at: Publisher Site | Google Scholar
F. Ovalle and R. Azziz, “Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus,” Fertility and Sterility, vol. 77, no. 6, pp. 1095–1105, 2002.
View at: Publisher Site | Google Scholar
R. S. Legro, “Polycystic ovary syndrome and cardiovascular disease: a premature association?” Endocrine Reviews, vol. 24, no. 3, pp. 302–312, 2003.
View at: Publisher Site | Google Scholar
P. Hardiman, O. S. Pillay, and W. Atiomo, “Polycystic ovary syndrome and endometrial carcinoma,” Lancet, vol. 361, no. 9371, pp. 1810–1812, 2003.
View at: Publisher Site | Google Scholar
H. E. Cooper, W. N. Spellacy, K. A. Prem, and W. D. Cohen, “Hereditary factors in the Stein-Leventhal syndrome,” American Journal of Obstetrics and Gynecology, vol. 100, no. 3, pp. 371–387, 1968.
View at: Google Scholar
R. S. Wilroy Jr., J. R. Givens, W. L. Wiser, S. A. Coleman, R. N. Andersen, and R. L. Summitt, “Hyperthecosis: an inheritable form of polycystic ovarian disease,” Birth Defects: Original Article Series, vol. 11, no. 4, pp. 81–85, 1975.
View at: Google Scholar
J. R. Givens, “Familial polycystic ovarian disease,” Endocrinology and Metabolism Clinics of North America, vol. 17, no. 4, pp. 771–783, 1988.
View at: Google Scholar
D. Ferriman and A. W. Purdie, “The inheritance of polycystic ovarian disease and a possible relationship to premature balding,” Clinical Endocrinology, vol. 11, no. 3, pp. 291–300, 1979.
View at: Google Scholar
O. Lunde, P. Magnus, L. Sandvik, and S. Hoglo, “Familial clustering in the polycystic ovarian syndrome,” Gynecologic and Obstetric Investigation, vol. 28, no. 1, pp. 23–30, 1989.
View at: Google Scholar
W. M. Hague, J. Adams, S. T. Reeders, T. E. A. Peto, and H. S. Jacobs, “Familial polycystic ovaries: a genetic disease?” Clinical Endocrinology, vol. 29, no. 6, pp. 593–605, 1988.
View at: Google Scholar
A. H. Carey, K. L. Chan, F. Short, D. White, R. Williamson, and S. Franks, “Evidence for a single gene effect causing polycystic ovaries and male pattern baldness,” Clinical Endocrinology, vol. 38, no. 6, pp. 653–658, 1993.
View at: Google Scholar
R. J. Norman, S. Masters, and W. Hague, “Hyperinsulinemia is common in family members of women with polycystic ovary syndrome,” Fertility and Sterility, vol. 66, no. 6, pp. 942–947, 1996.
View at: Google Scholar
S. Colilla, N. J. Cox, and D. A. Ehrmann, “Heritability of insulin secretion and insulin action in women with polycystic ovary syndrome and their first degree relatives,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 5, pp. 2027–2031, 2001.
View at: Publisher Site | Google Scholar
R. S. Legro, D. Driscoll, J. F. Strauss III, J. Fox, and A. Dunaif, “Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14956–14960, 1998.
View at: Publisher Site | Google Scholar
R. S. Legro, R. Bentley-Lewis, D. Driscoll, S. C. Wang, and A. Dunaif, “Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2128–2133, 2002.
View at: Publisher Site | Google Scholar
R. S. Legro, A. R. Kunselman, L. Demers, S. C. Wang, R. Bentley-Lewis, and A. Dunaif, “Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 5, pp. 2134–2138, 2002.
View at: Publisher Site | Google Scholar
M. D. Kahsar-Miller, C. Nixon, L. R. Boots, R. C. Go, and R. Azziz, “Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS,” Fertility and Sterility, vol. 75, no. 1, pp. 53–58, 2001.
View at: Publisher Site | Google Scholar
B. O. Yildiz, H. Yarali, H. Oguz, and M. Bayraktar, “Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 5, pp. 2031–2036, 2003.
View at: Publisher Site | Google Scholar
S. Franks, N. Gharani, D. Waterworth et al., “The genetic basis of polycystic ovary syndrome,” Human Reproduction, vol. 12, no. 12, pp. 2641–2648, 1997.
View at: Publisher Site | Google Scholar
S. Jahanfar and J. A. Eden, “Genetic and non-genetic theories on the etiology of polycystic ovary syndrome,” Gynecological Endocrinology, vol. 10, no. 5, pp. 357–364, 1996.
View at: Google Scholar
A. Govind, M. S. Obhrai, and R. N. Clayton, “Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 38–43, 1999.
View at: Publisher Site | Google Scholar
R. E. March, “Gene mapping by linkage and association analysis,” Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology, vol. 13, no. 2, pp. 113–122, 1999.
View at: Google Scholar
L. J. Palmer and L. R. Cardon, “Shaking the tree: mapping complex disease genes with linkage disequilibrium,” Lancet, vol. 366, no. 9492, pp. 1223–1234, 2005.
View at: Publisher Site | Google Scholar
G. McVean, C. C. Spencer, and R. Chaix, “Perspectives on human genetic variation from the HapMap Project,” PLoS Genetics, vol. 1, no. 4, p. e54, 2005.
View at: Publisher Site | Google Scholar
S. Franks, C. Gilling-Smith, N. Gharani, and M. McCarthy, “Pathogenesis of polycystic ovary syndrome: evidence for a genetically determined disorder of ovarian androgen production,” Human Fertility, vol. 3, no. 2, pp. 77–79, 2000.
View at: Google Scholar
N. Gharani, D. M. Waterworth, S. Batty et al., “Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism,” Human Molecular Genetics, vol. 6, no. 3, pp. 397–402, 1997.
View at: Publisher Site | Google Scholar
E. Diamanti-Kandarakis, M. I. Bartzis, A. T. Bergiele, T. C. Tsianateli, and C. R. Kouli, “Microsatellite polymorphism ${(t t t t a)}_{n}$ at -528 base pairs of gene CYP11 $α$ influences hyperandrogenemia in patients with polycystic ovary syndrome,” Fertility and Sterility, vol. 73, no. 4, pp. 735–741, 2000.
View at: Publisher Site | Google Scholar
Y. Wang, X.-K. Wu, Y.-X. Cao et al., “Microsatellite polymorphism of ${(t t t t a)}_{n}$ in the promoter of CYP11a gene in Chinese women with polycystic ovary syndrome,” Zhonghua Yi Xue Za Zhi, vol. 85, no. 48, pp. 3396–3400, 2005.
View at: Google Scholar
M. Gaasenbeek, B. L. Powell, U. Sovio et al., “Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2408–2413, 2004.
View at: Publisher Site | Google Scholar
L. Tan and G. Zhu, “Relationship between the microsatellite polymorphism of CYP11 $α$ gene and the pathogenesis of hyperandrogenism of polycystic ovary syndrome in Chinese,” Chinese Journal of Medical Genetics, vol. 22, no. 2, pp. 216–218, 2005.
View at: Google Scholar
L. Tan and G. Zhu, “Role of the pentanucleotide ${(t t t t a)}_{n}$ polymorphisms of Cyp11alpha gene in the pathogenesis of hyperandrogenism in Chinese women with polycystic ovary syndrome,” Journal of Huazhong University of Science and Technology. Medical Sciences, vol. 25, no. 2, pp. 212–214, 2005.
View at: Google Scholar
M. Urbanek, R. S. Legro, D. A. Driscoll et al., “Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 15, pp. 8573–8578, 1999.
View at: Publisher Site | Google Scholar
J. L. San Millán, J. Sancho, R. M. Calvo, and H. F. Escobar-Morreale, “Role of the pentanucleotide ${(t t t t a)}_{n}$ polymorphism in the promoter of the CYP11a gene in the pathogenesis of hirsutism,” Fertility and Sterility, vol. 75, no. 4, pp. 797–802, 2001.
View at: Publisher Site | Google Scholar
H. Escobar-Morreale, F. Pazos, N. Potau, R. Garcia-Robles, J. M. Sancho, and C. Varela, “Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 $α$ ,” Fertility and Sterility, vol. 62, no. 3, pp. 521–530, 1994.
View at: Google Scholar
R. Azziz, E. L. Bradley Jr., H. D. Potter, and L. R. Boots, “Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 2, pp. 400–405, 1995.
View at: Publisher Site | Google Scholar
S. F. Witchel and C. E. Aston, “The role of heterozygosity for CYP21 in the polycystic ovary syndrome,” Journal of Pediatric Endocrinology and Metabolism, vol. 13, 5, pp. 1315–1317, 2000.
View at: Google Scholar
S. F. Witchel, P. A. Lee, M. Suda-Hartman, and E. P. Hoffman, “Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency,” Biochemical and Molecular Medicine, vol. 62, no. 2, pp. 151–158, 1997.
View at: Publisher Site | Google Scholar
H. F. Escobar-Morreale, J. L. San Millán, R. R. Smith, J. Sancho, and S. F. Witchel, “The presence of the 21-hydroxylase deficiency carrier status in hirsute women: phenotype-genotype correlations,” Fertility and Sterility, vol. 72, no. 4, pp. 629–638, 1999.
View at: Publisher Site | Google Scholar
D. Glintborg, A. P. Hermann, K. Brusgaard, J. Hangaard, C. Hagen, and M. Andersen, “Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1347–1353, 2005.
View at: Publisher Site | Google Scholar
S. F. Witchel, M. Kahsar-Miller, C. E. Aston, C. White, and R. Azziz, “Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess,” Fertility and Sterility, vol. 83, no. 2, pp. 371–375, 2005.
View at: Publisher Site | Google Scholar
J. Picado-Leonard and W. L. Miller, “Cloning and sequence of the human gene for P450c17 (steroid 17 $α$ -hydroxylase/17,20 lyase): similarity with the gene for P450c21,” DNA, vol. 6, no. 5, pp. 439–448, 1987.
View at: Google Scholar
L. Sharp, A. H. Cardy, S. C. Cotton, and J. Little, “CYP17 gene polymorphisms: prevalence and associations with hormone levels and related factors. A HuGE review,” American Journal of Epidemiology, vol. 160, no. 8, pp. 729–740, 2004.
View at: Publisher Site | Google Scholar
R. L. Rosenfield, R. B. Barnes, J. F. Cara, and A. W. Lucky, “Dysregulation of cytochrome P450c 17 $α$ as the cause of polycystic ovarian syndrome,” Fertility and Sterility, vol. 53, no. 5, pp. 785–791, 1990.
View at: Google Scholar
R. L. Rosenfield, R. B. Barnes, and D. A. Ehrmann, “Studies of the nature of 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism,” Journal of Clinical Endocrinology and Metabolism, vol. 79, no. 6, pp. 1686–1692, 1994.
View at: Publisher Site | Google Scholar
H. F. Escobar-Morreale, J. Serrano-Gotarredona, R. García-Robles, J. M. Sancho, and C. Varela, “Lack of an ovarian function influence on the increased adrenal androgen secretion present in women with functional ovarian hyperandrogenism,” Fertility and Sterility, vol. 67, no. 4, pp. 654–662, 1997.
View at: Publisher Site | Google Scholar
J. K. Wickenheisser, P. G. Quinn, V. L. Nelson, R. S. Legro, J. F. Strauss III, and J. M. McAllister, “Differential activity of the cytochrome P450 17 $α$ -hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 6, pp. 2304–2311, 2000.
View at: Publisher Site | Google Scholar
J. K. Wickenheisser, V. L. Nelson-Degrave, P. G. Quinn, and J. M. McAllister, “Increased cytochrorne P450 17 $α$ -hydroxylase promoter function in theca cells isolated from patients with polycystic ovary syndrome involves nuclear factor-1,” Molecular Endocrinology, vol. 18, no. 3, pp. 588–605, 2004.
View at: Publisher Site | Google Scholar
J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister, “Dysregulation of cytochrome P450 17 $α$ -hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1720–1727, 2005.
View at: Publisher Site | Google Scholar
A. H. Carey, D. Waterworth, K. Patel et al., “Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17,” Human Molecular Genetics, vol. 3, no. 10, pp. 1873–1876, 1994.
View at: Google Scholar
E. Diamanti-Kandarakis, M. I. Bartzis, E. D. Zapanti et al., “Polymorphism $T ? C$ (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome,” Fertility and Sterility, vol. 71, no. 3, pp. 431–435, 1999.
View at: Publisher Site | Google Scholar
N. Gharani, D. M. Waterworth, R. Williamson, and S. Franks, “ $5^{'}$ polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 11, p. 4174, 1996.
View at: Publisher Site | Google Scholar
K. Techatraisak, G. S. Conway, and G. Rumsby, “Frequency of a polymorphism in the regulatory region of the 17 $α$ -hydroxylase-17,20-lyase (CYP17) gene in hyperandrogenic states,” Clinical Endocrinology, vol. 46, no. 2, pp. 131–134, 1997.
View at: Publisher Site | Google Scholar
S. F. Witchel, P. A. Lee, M. Suda-Hartman, R. Smith, and E. P. Hoffman, “17 $α$ -hydroxylase/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17,” Journal of Pediatric and Adolescent Gynecology, vol. 11, no. 3, pp. 133–137, 1998.
View at: Google Scholar
B. Marszalek, M. Lacinski, N. Babych et al., “Investigations on the genetic polymorphism in the region of CYP17 gene encoding $5^{'}$ -UTR in patients with polycystic ovarian syndrome,” Gynecological Endocrinology, vol. 15, no. 2, pp. 123–128, 2001.
View at: Google Scholar
M. Kahsar-Miller, L. R. Boots, A. Bartolucci, and R. Azziz, “Role of a CYP17 polymorphism in the regulation of circulating dehydroepiandrosterone sulfate levels in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 82, no. 4, pp. 973–975, 2004.
View at: Publisher Site | Google Scholar
L.-H. Zhang, H. Rodriguez, S. Ohno, and W. L. Miller, “Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 23, pp. 10619–10623, 1995.
View at: Publisher Site | Google Scholar
K.-N. Qin and R. L. Rosenfield, “Role of cytochrome P450c17 in polycystic ovary syndrome,” Molecular and Cellular Endocrinology, vol. 145, no. 1-2, pp. 111–121, 1998.
View at: Publisher Site | Google Scholar
S. Takayama, M. F. White, and C. R. Kahn, “Phorbol ester-induced serine phosphorylation of the insulin receptor decreases its tyrosine kinase activity,” Journal of Biological Chemistry, vol. 263, no. 7, pp. 3440–3447, 1988.
View at: Google Scholar
J. E. Chin, M. Dickens, J. M. Tavare, and R. A. Roth, “Overexpression of protein kinase C isoenzymes $α$ , $β$ I, $γ$ , and $ε$ in cells overexpressing the insulin receptor. Effects on receptor phosphorylation and signaling,” Journal of Biological Chemistry, vol. 268, no. 9, pp. 6338–6347, 1993.
View at: Google Scholar
A. Dunaif, J. Xia, C.-B. Book, E. Schenker, and Z. Tang, “Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome,” Journal of Clinical Investigation, vol. 96, no. 2, pp. 801–810, 1995.
View at: Google Scholar
A. Dunaif, “Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis,” Endocrine Reviews, vol. 18, no. 6, pp. 774–800, 1997.
View at: Publisher Site | Google Scholar
E. R. Simpson, M. S. Mahendroo, G. D. Means et al., “Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis,” Endocrine Reviews, vol. 15, no. 3, pp. 342–355, 1994.
View at: Publisher Site | Google Scholar
D. W. Nebert, M. Adesnik, M. J. Coon et al., “The P450 gene superfamily: recommended nomenclature,” DNA, vol. 6, no. 1, pp. 1–11, 1987.
View at: Google Scholar
S. Chen, M. J. Besman, R. S. Sparkes et al., “Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15,” DNA, vol. 7, no. 1, pp. 27–38, 1988.
View at: Google Scholar
N. Harada, H. Ogawa, M. Shozu, and K. Yamada, “Genetic studies to characterize the origin of the mutation in placental aromatase deficiency,” American Journal of Human Genetics, vol. 51, no. 3, pp. 666–672, 1992.
View at: Google Scholar
Y. Ito, C. R. Fisher, F. A. Conte, M. M. Grumbach, and E. R. Simpson, “Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11673–11677, 1993.
View at: Publisher Site | Google Scholar
K. Takayama, T. Fukaya, H. Sasano et al., “Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome,” Human Reproduction, vol. 11, no. 7, pp. 1387–1392, 1996.
View at: Google Scholar
G. F. Erickson, A. J. W. Hsueh, M. E. Quigley, R. W. Rebar, and S. S. Yen, “Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries,” Journal of Clinical Endocrinology and Metabolism, vol. 49, no. 4, pp. 514–519, 1979.
View at: Google Scholar
A. J. Jakimiuk, S. R. Weitsman, P. R. Brzechffa, and D. A. Magoffin, “Aromatase mRNA expression in individual follicles from polycystic ovaries,” Molecular Human Reproduction, vol. 4, no. 1, pp. 1–8, 1998.
View at: Publisher Site | Google Scholar
D. Söderlund, P. Canto, S. Carranza-Lira, and J. P. Méndez, “No evidence of mutations in the P450 aromatase gene in patients with polycystic ovary syndrome,” Human Reproduction, vol. 20, no. 4, pp. 965–969, 2005.
View at: Publisher Site | Google Scholar
C. J. Petry, K. K. Ong, K. F. Michelmore et al., “Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women,” Human Reproduction, vol. 20, no. 7, pp. 1837–1843, 2005.
View at: Publisher Site | Google Scholar
C. J. Petry, K. K. Ong, K. F. Michelmore et al., “Associations between common variation in the aromatase gene promoter region and testosterone concentrations in two young female populations,” Journal of Steroid Biochemistry and Molecular Biology, vol. 98, no. 4-5, pp. 199–206, 2006.
View at: Publisher Site | Google Scholar
D. B. Lubahn, D. R. Joseph, P. M. Sullivan, H. F. Willard, F. S. French, and E. M. Wilson, “Cloning of human androgen receptor complementary DNA and localization to the X chromomose,” Science, vol. 240, no. 4850, pp. 327–330, 1988.
View at: Publisher Site | Google Scholar
M. A. Carson-Jurica, W. T. Schrader, and B. W. O'Malley, “Steroid receptor family: structure and functions,” Endocrine Reviews, vol. 11, no. 2, pp. 201–220, 1990.
View at: Google Scholar
N. L. Chamberlain, E. D. Driver, and R. L. Miesfeld, “The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function,” Nucleic Acids Research, vol. 22, no. 15, pp. 3181–3186, 1994.
View at: Google Scholar
E. Giovannucci, M. J. Stampfer, K. Krithivas et al., “The CAG repeat within the androgen receptor gene and its relationship to prostate cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 7, pp. 3320–3323, 1997.
View at: Publisher Site | Google Scholar
T. G. Tut, F. J. Ghadessy, M. A. Trifiro, L. Pinsky, and E. L. Yong, “Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 11, pp. 3777–3782, 1997.
View at: Publisher Site | Google Scholar
A. T. Dowsing, E. L. Yong, M. Clark, R. I. McLachlan, D. M. De Kretser, and A. O. Trounson, “Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene,” Lancet, vol. 354, no. 9179, pp. 640–643, 1999.
View at: Publisher Site | Google Scholar
T. R. Rebbeck, P. W. Kantoff, K. Krithivas et al., “Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat,” American Journal of Human Genetics, vol. 64, no. 5, pp. 1371–1377, 1999.
View at: Publisher Site | Google Scholar
A. Mifsud, S. Ramirez, and E. L. Yong, “Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 9, pp. 3484–3488, 2000.
View at: Publisher Site | Google Scholar
T. Hickey, A. Chandy, and R. J. Norman, “The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 1, pp. 161–165, 2002.
View at: Publisher Site | Google Scholar
J. Jääskeläinen, S. Korhonen, R. Voutilainen, M. Hippeläinen, and S. Heinonen, “Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 83, no. 6, pp. 1724–1728, 2005.
View at: Publisher Site | Google Scholar
M. Pugeat, J. C. Crave, J. Tourniaire, and M. G. Forest, “Clinical utility of sex hormone-binding globulin measurement,” Hormone Research, vol. 45, no. 3–5, pp. 148–155, 1996.
View at: Google Scholar
C. Selby, “Sex hormone binding globulin: origin, function and clinical significance,” Annals of Clinical Biochemistry, vol. 27, part 6, pp. 532–541, 1990.
View at: Google Scholar
D. Berube, G. E. Seralini, R. Gagne, and G. L. Hammond, “Localization of the human sex hormone-binding globulin gene (SHBG) to the short arm of chromosome 17 (17p12 $\to$ p13),” Cytogenetics and Cell Genetics, vol. 54, no. 1-2, pp. 65–67, 1990.
View at: Google Scholar
K. N. Hogeveen, M. Talikka, and G. L. Hammond, “Human sex hormone-binding globulin promoter activity is influenced by a ${(TAAAA)}_{n}$ repeat element within an Alu sequence,” Journal of Biological Chemistry, vol. 276, no. 39, pp. 36383–36390, 2001.
View at: Publisher Site | Google Scholar
N. Xita, A. Tsatsoulis, A. Chatzikyriakidou, and I. Georgiou, “Association of the ${(TAAAA)}_{n}$ repeat polymorphism in the sex hormone-binding globulin (SHBG) gene with polycystic ovary syndrome and relation to SHBG serum levels,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5976–5980, 2003.
View at: Publisher Site | Google Scholar
P. Cousin, L. Calemard-Michel, H. Lejeune et al., “Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 2, pp. 917–924, 2004.
View at: Publisher Site | Google Scholar
A. H. Balen, “Hypersecretion of luteinizing hormone and the polycystic ovary syndrome,” Human Reproduction, vol. 8, 2, pp. 123–128, 1993.
View at: Google Scholar
J. E. Hall, A. E. Taylor, K. A. Martin, and W. F. Crowley, “New approaches to the study of the neuroendocrine abnormalities of women with the polycystic ovarian syndrome,” Annals of the New York Academy of Sciences, vol. 687, pp. 182–192, 1993.
View at: Publisher Site | Google Scholar
K. Furui, N. Suganuma, S.-I. Tsukahara et al., “Identification of two point mutations in the gene coding luteinizing hormone (LH) $ß$ -subunit, associated with immunologically anomalous LH variants,” Journal of Clinical Endocrinology and Metabolism, vol. 78, no. 1, pp. 107–113, 1994.
View at: Publisher Site | Google Scholar
C. Nilsson, K. Pettersson, R. P. Millar, K. A. Coerver, M. M. Matzuk, and I. T. Huhtaniemi, “Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research,” Fertility and Sterility, vol. 67, no. 6, pp. 998–1004, 1997.
View at: Publisher Site | Google Scholar
K. Okuda, T. Yamada, H. Imoto, H. Komatsubara, and O. Sugimoto, “Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions,” Biochemical and Biophysical Research Communications, vol. 200, no. 1, pp. 584–590, 1994.
View at: Publisher Site | Google Scholar
A.-M. Haavisto, K. Pettersson, M. Bergendahl, A. Virkamaki, and I. Huhtaniemi, “Occurrence and biological properties of a common genetic variant of luteinizing hormone,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 4, pp. 1257–1263, 1995.
View at: Publisher Site | Google Scholar
M. Rajkhowa, J. A. Talbot, P. W. Jones et al., “Prevalence of an immunological LH $ß$ -subunit variant in a UK population of healthy women and women with polycystic ovary syndrome,” Clinical Endocrinology, vol. 43, no. 3, pp. 297–303, 1995.
View at: Google Scholar
J. S. Tapanainen, R. Koivunen, B. C. J. M. Fauser et al., “A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 5, pp. 1711–1715, 1999.
View at: Publisher Site | Google Scholar
L. N. Ramanujam, W. X. Liao, A. C. Roy, A. Loganath, H. H. Goh, and S. C. Ng, “Association of molecular variants of luteinizing hormone with menstrual disorders,” Clinical Endocrinology, vol. 51, no. 2, pp. 243–246, 1999.
View at: Publisher Site | Google Scholar
K. Elter, C. T. Erel, N. Cine, U. Ozbek, B. Hacihanefioglu, and E. Ertungealp, “Role of the mutations Trp8 $\to$ Arg and Ile15 $\to$ Thr of the human luteinizing hormone $β$ -subunit in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 71, no. 3, pp. 425–430, 1999.
View at: Publisher Site | Google Scholar
A. C. Roy, W.-X. Liao, Y. Chen, S. Arulkumaran, and S. S. Ratnam, “Identification of seven novel mutations in LH $β$ -subunit gene by SSCP,” Molecular and Cellular Biochemistry, vol. 165, no. 2, pp. 151–153, 1996.
View at: Publisher Site | Google Scholar
K. Takahashi, K. Karino, H. Kanasaki et al., “Influence of missense mutation and silent mutation of LH $ß$ -subunit gene in Japanese patients with ovulatory disorders,” European Journal of Human Genetics, vol. 11, no. 5, pp. 402–408, 2003.
View at: Publisher Site | Google Scholar
S. Franks, N. Gharani, and M. McCarthy, “Candidate genes in polycystic ovary syndrome,” Human Reproduction Update, vol. 7, no. 4, pp. 405–410, 2001.
View at: Publisher Site | Google Scholar
P. G. Knight and C. Glister, “Potential local regulatory functions of inhibins, activins and follistatin in the ovary,” Reproduction, vol. 121, no. 4, pp. 503–512, 2001.
View at: Publisher Site | Google Scholar
Q. Guo, T. R. Kumar, T. Woodruff, L. A. Hadsell, F. J. DeMayo, and M. M. Matzuk, “Overexpression of mouse follistatin causes reproductive defects in transgenic mice,” Molecular Endocrinology, vol. 12, no. 1, pp. 96–106, 1998.
View at: Publisher Site | Google Scholar
J. P. Mather, A. Moore, and R.-H. Li, “Activins, inhibins, and follistatins: further thoughts on a growing family of regulators,” Proceedings of the Society for Experimental Biology and Medicine, vol. 215, no. 3, pp. 209–222, 1997.
View at: Google Scholar
H. Shibata, M. Kanzaki, T. Takeuchi, J.-I. Miyazaki, and I. Kojima, “Two distinct signaling pathways activated by activin a in glucose-responsive pancreatic $β$ -cell lines,” Journal of Molecular Endocrinology, vol. 16, no. 3, pp. 249–258, 1996.
View at: Google Scholar
R. S. Legro, R. Spielman, M. Urbanek, D. Driscoll, J. F. Strauss III, and A. Dunaif, “Phenotype and genotype in polycystic ovary syndrome,” Recent Progress in Hormone Research, vol. 53, pp. 217–256, 1998.
View at: Google Scholar
M. Urbanek, X. Wu, K. R. Vickery et al., “Allelic variants of the follistatin gene in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4455–4461, 2000.
View at: Publisher Site | Google Scholar
W. X. Liao, A. C. Roy, and S. C. Ng, “Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome,” Molecular Human Reproduction, vol. 6, no. 7, pp. 587–590, 2000.
View at: Publisher Site | Google Scholar
R. M. Calvo, G. Villuendas, J. Sancho, J. L. San Millán, and H. F. Escobar-Morreale, “Role of the follistatin gene in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 75, no. 5, pp. 1020–1023, 2001.
View at: Publisher Site | Google Scholar
A. Dunaif, K. R. Segal, W. Futterweit, and A. Dobrjansky, “Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome,” Diabetes, vol. 38, no. 9, pp. 1165–1174, 1989.
View at: Google Scholar
C. Junien and V. van Heyningen, “Report of the committee on the genetic constitution of chromosome 11,” Cytogenetics and Cell Genetics, vol. 55, no. 1–4, pp. 153–169, 1990.
View at: Google Scholar
G. C. Kennedy, M. S. German, and W. J. Rutter, “The minisatellite in the diabetes susceptibility locus IDDM2 regulates insulin transcription,” Nature Genetics, vol. 9, no. 3, pp. 293–298, 1995.
View at: Publisher Site | Google Scholar
J. Paquette, N. Giannoukakis, C. Polychronakos, P. Vafiadis, and C. Deal, “The INS $5^{'}$ variable number of tandem repeats is associated with IGF2 expression in humans,” Journal of Biological Chemistry, vol. 273, no. 23, pp. 14158–14164, 1998.
View at: Publisher Site | Google Scholar
G. I. Bell, M. J. Selby, and W. J. Rutter, “The highly polymorphic region near the human insulin gene is composed of simple tandemly repeating sequences,” Nature, vol. 295, no. 5844, pp. 31–35, 1982.
View at: Publisher Site | Google Scholar
J. U. Weaver, P. G. Kopelman, and G. A. Hitman, “Central obesity and hyperinsulinaemia in women are associated with polymorphism in the $5^{'}$ flanking region of the human insulin gene,” European Journal of Clinical Investigation, vol. 22, no. 4, pp. 265–270, 1992.
View at: Google Scholar
K. K. L. Ong, D. I. Phillips, C. Fall et al., “The insulin gene VNTR, type 2 diabetes and birth weight,” Nature Genetics, vol. 21, no. 3, pp. 262–263, 1999.
View at: Publisher Site | Google Scholar
A. Dunaif, K. R. Segal, D. R. Shelley, G. Green, A. Dobrjansky, and T. Licholai, “Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome,” Diabetes, vol. 41, no. 10, pp. 1257–1266, 1992.
View at: Google Scholar
J. Holte, T. Bergh, C. Berne, L. Wide, and H. Lithell, “Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 9, pp. 2586–2593, 1995.
View at: Publisher Site | Google Scholar
N. M. O'Meara, J. D. Blackman, D. A. Ehrmann et al., “Defects in $ß$ -cell function in functional ovarian hyperandrogenism,” Journal of Clinical Endocrinology and Metabolism, vol. 76, no. 5, pp. 1241–1247, 1993.
View at: Publisher Site | Google Scholar
D. M. Waterworth, S. T. Bennett, N. Gharani et al., “Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome,” Lancet, vol. 349, no. 9057, pp. 986–990, 1997.
View at: Publisher Site | Google Scholar
I. A. Eaves, S. T. Bennett, P. Forster et al., “Transmission ratio distortion at the INS-IGF2 VNTR,” Nature Genetics, vol. 22, no. 4, pp. 324–325, 1999.
View at: Publisher Site | Google Scholar
K. Michelmore, K. Ong, S. Mason et al., “Clinical features in women with polycystic ovaries: relationships to insulin sensitivity, insulin gene VNTR and birth weight,” Clinical Endocrinology, vol. 55, no. 4, pp. 439–446, 2001.
View at: Publisher Site | Google Scholar
R. M. Calvo, D. Tellería, J. Sancho, J. L. San Millán, and H. F. Escobar-Morreale, “Insulin gene variable number of tandem repeats regulatory polymorphism is not associated with hyperandrogenism in Spanish women,” Fertility and Sterility, vol. 77, no. 4, pp. 666–668, 2002.
View at: Publisher Site | Google Scholar
M. Vanková, J. Vrbíková, M. Hill, O. Cinek, and B. Bendlová, “Association of insulin gene VNTR polymorphism with polycystic ovary syndrome,” Annals of the New York Academy of Sciences, vol. 967, pp. 558–565, 2002.
View at: Google Scholar
J. P. A. Ioannidis, T. A. Trikalinos, E. E. Ntzani, and D. G. Contopoulos-Ioannidis, “Genetic associations in large versus small studies: an empirical assessment,” Lancet, vol. 361, no. 9357, pp. 567–571, 2003.
View at: Publisher Site | Google Scholar
B. L. Powell, L. Haddad, A. Bennett et al., “Analysis of multiple data sets reveals no association between the insulin gene variable number tandem repeat element and polycystic ovary syndrome or related traits,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2988–2993, 2005.
View at: Publisher Site | Google Scholar
I. D. Goldfine, “The insulin receptor: molecular biology and transmembrane signaling,” Endocrine Reviews, vol. 8, no. 3, pp. 235–255, 1987.
View at: Google Scholar
L. R. Sorbara, Z. Tang, A. Cama et al., “Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome,” Metabolism, vol. 43, no. 12, pp. 1568–1574, 1994.
View at: Publisher Site | Google Scholar
G. S. Conway, C. Avey, and G. Rumsby, “The tyrosine kinase domain of the insulin receptor gene is normal in women with hyperinsulinaemia and polycystic ovary syndrome,” Human Reproduction, vol. 9, no. 9, pp. 1681–1683, 1994.
View at: Google Scholar
J. A. Talbot, E. J. Bicknell, M. Rajkhowa, A. Krook, S. O'Rahilly, and R. N. Clayton, “Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 5, pp. 1979–1983, 1996.
View at: Publisher Site | Google Scholar
S. Tucci, W. Futterweit, E. S. Concepcion et al., “Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 1, pp. 446–449, 2001.
View at: Publisher Site | Google Scholar
G. Villuendas, H. F. Escobar-Morreale, F. Tosi, J. Sancho, P. Moghetti, and J. L. San Millán, “Association between the D19S884 marker at the insulin receptor gene locus and polycystic ovary syndrome,” Fertility and Sterility, vol. 79, no. 1, pp. 219–220, 2003.
View at: Publisher Site | Google Scholar
M. Urbanek, A. Woodroffe, K. G. Ewens et al., “Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 12, pp. 6623–6629, 2005.
View at: Publisher Site | Google Scholar
S. Siegel, W. Futterweit, T. F. Davies et al., “A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome,” Fertility and Sterility, vol. 78, no. 6, pp. 1240–1243, 2002.
View at: Publisher Site | Google Scholar
S. R. Hubbard, L. Wei, L. Ellis, and W. A. Hendrickson, “Crystal structure of the tyrosine kinase domain of the human insulin receptor,” Nature, vol. 372, no. 6508, pp. 746–754, 1994.
View at: Publisher Site | Google Scholar
M. F. White, “IRS proteins and the common path to diabetes,” American Journal of Physiology - Endocrinology and Metabolism, vol. 283, no. 3, pp. E413–E422, 2002.
View at: Google Scholar
D. J. Burks and M. F. White, “IRS proteins and beta-cell function,” Diabetes, vol. 50, 1, pp. S140–S145, 2001.
View at: Google Scholar
A. Jellema, M. P. A. Zeegers, E. J. M. Feskens, P. C. Dagnelie, and R. P. Mensink, “Gly972Arg variant in the insulin receptor substrate-1 gene and association with type 2 diabetes: a meta-analysis of 27 studies,” Diabetologia, vol. 46, no. 7, pp. 990–995, 2003.
View at: Publisher Site | Google Scholar
T. Sir-Petermann, F. Pérez-Bravo, B. Angel, M. Maliqueo, M. Calvillan, and A. Palomino, “G972R polymorphism of IRS-1 in women with polycystic ovary syndrome,” Diabetologia, vol. 44, no. 9, pp. 1200–1201, 2001.
View at: Publisher Site | Google Scholar
S. A. El Mkadem, C. Lautier, F. Macari et al., “Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome,” Diabetes, vol. 50, no. 9, pp. 2164–2168, 2001.
View at: Google Scholar
D. A. Ehrmann, X. Tang, I. Yoshiuchi, N. J. Cox, and G. I. Bell, “Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 9, pp. 4297–4300, 2002.
View at: Publisher Site | Google Scholar
G. Villuendas, J. I. Botella-Carretero, B. Roldán, J. Sancho, H. F. Escobar-Morreale, and J. L. San Millán, “Polymorphisms in the insulin receptor substrate-1 (IRS-1) gene and the insulin receptor substrate-2 (IRS-2) gene influence glucose homeostasis and body mass index in women with polycystic ovary syndrome and non-hyperandrogenic controls,” Human Reproduction, vol. 20, no. 11, pp. 3184–3191, 2005.
View at: Publisher Site | Google Scholar
S. Dilek, D. Ertunc, E. C. Tok, E. M. Erdal, and A. Aktas, “Association of Gly972Arg variant of insulin receptor substrate-1 with metabolic features in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 84, no. 2, pp. 407–412, 2005.
View at: Publisher Site | Google Scholar
D. Ertunc, E. C. Tok, A. Aktas, E. M. Erdal, and S. Dilek, “The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome,” Human Reproduction, vol. 20, no. 5, pp. 1207–1212, 2005.
View at: Publisher Site | Google Scholar
N. F. Wiernsperger and C. J. Bailey, “The antihyperglycaemic effect of metformin therapeutic and cellular mechanisms,” Drugs, vol. 58, 1, pp. 31–39, 1999, discussion 75–82.
View at: Publisher Site | Google Scholar
S. K. Sreenan, Y.-P. Zhou, K. Otani et al., “Calpains play a role in insulin secretion and action,” Diabetes, vol. 50, no. 9, pp. 2013–2020, 2001.
View at: Google Scholar
Y. Horikawa, N. Oda, N. J. Cox et al., “Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus,” Nature Genetics, vol. 26, no. 2, pp. 163–175, 2000.
View at: Publisher Site | Google Scholar
D. A. Ehrmann, “Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus,” Baillière's Clinical Obstetrics and Gynaecology, vol. 11, no. 2, pp. 335–347, 1997.
View at: Publisher Site | Google Scholar
D. A. Ehrmann, P. E. H. Schwarz, M. Hara et al., “Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1669–1673, 2002.
View at: Publisher Site | Google Scholar
A. Gonzalez, E. Abril, A. Roca et al., “Comment: CAPN10 alleles are associated with polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3971–3976, 2002.
View at: Publisher Site | Google Scholar
A. Gonzalez, E. Abril, A. Roca et al., “Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 5529–5536, 2003.
View at: Publisher Site | Google Scholar
L. Haddad, J. C. Evans, N. Gharani et al., “Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 6, pp. 2606–2610, 2002.
View at: Publisher Site | Google Scholar
H. F. Escobar-Morreale, B. Peral, G. Villuendas, R. M. Calvo, J. Sancho, and J. L. San Millán, “Common single nucleotide polymorphisms in intron 3 of the calpain-10 gene influence hirsutism,” Fertility and Sterility, vol. 77, no. 3, pp. 581–587, 2002.
View at: Publisher Site | Google Scholar
E. E. Kershaw and J. S. Flier, “Adipose tissue as an endocrine organ,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2548–2556, 2004.
View at: Publisher Site | Google Scholar
L. Oksanen, A. Tiitinen, J. Kaprio, H. A. Koistinen, S.-L. Karonen, and K. Kontula, “No evidence for mutations of the leptin or leptin receptor genes in women with polycystic ovary syndrome,” Molecular Human Reproduction, vol. 6, no. 10, pp. 873–876, 2000.
View at: Publisher Site | Google Scholar
F. B. Hu, A. Doria, T. Li et al., “Genetic variation at the adiponectin locus and risk of type 2 diabetes in women,” Diabetes, vol. 53, no. 1, pp. 209–213, 2004.
View at: Google Scholar
K. Hara, P. Boutin, Y. Mori et al., “Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population,” Diabetes, vol. 51, no. 2, pp. 536–540, 2002.
View at: Google Scholar
M. Stumvoll, O. Tschritter, A. Fritsche et al., “Association of the T-G polymorphism in adiponectin (Exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes,” Diabetes, vol. 51, no. 1, pp. 37–41, 2002.
View at: Google Scholar
C. Menzaghi, T. Ercolino, R. Di Paola et al., “A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome,” Diabetes, vol. 51, no. 7, pp. 2306–2312, 2002.
View at: Google Scholar
J. L. San Millán, M. Cortón, G. Villuendas, J. Sancho, B. Peral, and H. F. Escobar-Morreale, “Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2640–2646, 2004.
View at: Google Scholar
D. Panidis, A. Kourtis, A. Kukuvitis et al., “Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of $?$ 4-androstenedione,” Human Reproduction, vol. 19, no. 8, pp. 1728–1733, 2004.
View at: Google Scholar
N. Xita, I. Georgiou, A. Chatzikyriakidou et al., “Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome,” Clinical Chemistry, vol. 51, no. 2, pp. 416–423, 2005.
View at: Publisher Site | Google Scholar
H. F. Escobar-Morreale, G. Villuendas, J. I. Botella-Carretero et al., “Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study,” Human Reproduction, vol. 21, no. 9, pp. 2257–2265, 2006.
View at: Publisher Site | Google Scholar
S. M. Rangwala and M. A. Lazar, “Peroxisome proliferator-activated receptor $γ$ in diabetes and metabolism,” Trends in Pharmacological Sciences, vol. 25, no. 6, pp. 331–336, 2004.
View at: Publisher Site | Google Scholar
A. Elbrecht, Y. Chen, C. A. Cullinan et al., “Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors $?$ 1 and $?$ 2,” Biochemical and Biophysical Research Communications, vol. 224, no. 2, pp. 431–437, 1996.
View at: Publisher Site | Google Scholar
A. J. Vidal-Puig, R. V. Considine, M. Jimenez-Liñan et al., “Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids,” Journal of Clinical Investigation, vol. 99, no. 10, pp. 2416–2422, 1997.
View at: Google Scholar
P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, and B. M. Spiegelman, “mPPAR $γ$ 2: tissue-specific regulator of an adipocyte enhancer,” Genes and Development, vol. 8, no. 10, pp. 1224–1234, 1994.
View at: Google Scholar
D. Altshuler, J. N. Hirschhorn, M. Klannemark et al., “The common PPAR $?$ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes,” Nature Genetics, vol. 26, no. 1, pp. 76–80, 2000.
View at: Publisher Site | Google Scholar
A. Dunaif, D. Scott, D. Finegood, B. Quintana, and R. Whitcomb, “The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 9, pp. 3299–3306, 1996.
View at: Publisher Site | Google Scholar
R. Azziz, D. Ehrmann, R. S. Legro et al., “Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 4, pp. 1626–1632, 2001.
View at: Publisher Site | Google Scholar
G. Ghazeeri, W. H. Kutteh, M. Bryer-Ash, D. Haas, and R. W. Ke, “Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 79, no. 3, pp. 562–566, 2003.
View at: Publisher Site | Google Scholar
A. Meirhaeghe and P. Amouyel, “Impact of genetic variation of PPAR $γ$ in humans,” Molecular Genetics and Metabolism, vol. 83, no. 1-2, pp. 93–102, 2004.
View at: Publisher Site | Google Scholar
M. Hara, S. Y. Alcoser, A. Qaadir, K. K. Beiswenger, N. J. Cox, and D. A. Ehrmann, “Insulin resistance is attenuated in women with polycystic ovary syndrome with the Pro12Ala polymorphism in the ppar $γ$ gene,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 772–775, 2002.
View at: Publisher Site | Google Scholar
S. Hahn, A. Fingerhut, U. Khomtsiv et al., “The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome,” Clinical Endocrinology, vol. 62, no. 5, pp. 573–579, 2005.
View at: Publisher Site | Google Scholar
E. C. Tok, A. Aktas, D. Ertunc, E. M. Erdal, and S. Dilek, “Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)- $γ$ 2 Pro12Ala genotype,” Human Reproduction, vol. 20, no. 6, pp. 1590–1595, 2005.
View at: Publisher Site | Google Scholar
S. Korhonen, S. Heinonen, M. Hiltunen et al., “Polymorphism in the peroxisome proliferator-activated receptor- $?$ gene in women with polycystic ovary syndrome,” Human Reproduction, vol. 18, no. 3, pp. 540–543, 2003.
View at: Google Scholar
M. Yilmaz, M. A. Ergün, A. Karakoç et al., “Pro12Ala polymorphism of the peroxisome proliferator-activated receptor- $?$ gene in first-degree relatives of subjects with polycystic ovary syndrome,” Gynecological Endocrinology, vol. 21, no. 4, pp. 206–210, 2005.
View at: Publisher Site | Google Scholar
M. Yilmaz, M. A. Ergün, A. Karakoç, E. Yurtçu, N. Çakir, and M. Arslan, “Pro12Ala polymorphism of the peroxisome proliferator-activated receptor- $γ$ gene in women with polycystic ovary syndrome,” Gynecological Endocrinology, vol. 22, no. 6, pp. 336–342, 2006.
View at: Publisher Site | Google Scholar
F. Orio Jr., G. Matarese, S. Di Biase et al., “Exon 6 and 2 peroxisome proliferator-activated receptor- $?$ polymorphisms in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5887–5892, 2003.
View at: Google Scholar
Y. Wang, X. Wu, Y. Cao, L. Yi, H. Fan, and J. Chen, “Polymorphisms of the peroxisome proliferator-activated receptor- $γ$ and its coactivator-1 $α$ genes in Chinese women with polycystic ovary syndrome,” Fertility and Sterility, vol. 85, no. 5, pp. 1536–1540, 2006.
View at: Publisher Site | Google Scholar
F. Orio Jr., S. Palomba, T. Cascella et al., “Lack of an association between peroxisome proliferator-activated receptor- $?$ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 10, pp. 5110–5115, 2004.
View at: Publisher Site | Google Scholar
C. R. Milner, J. E. Craig, N. D. Hussey, and R. J. Norman, “No association between the -308 polymorphism in the tumour necrosis favor $α$ (TNF $α$ ) promoter region and polycystic ovaries,” Molecular Human Reproduction, vol. 5, no. 1, pp. 5–9, 1999.
View at: Google Scholar
W. Mao, L. Yu, and Y. Chen, “Study on the relationship between a polymorphism of tumor necrosis factor- $α$ gene and the pathogenesis of polycystic ovary syndrome,” Zhonghua Fu Chan Ke Za Zhi, vol. 35, no. 9, pp. 536–539, 2000.
View at: Google Scholar
S. Korhonen, E.-L. Romppanen, M. Hiltunen et al., “Lack of association between C-850T polymorphism of the gene encoding tumor necrosis factor- $a$ and polycystic ovary syndrome,” Gynecological Endocrinology, vol. 16, no. 4, pp. 271–274, 2002.
View at: Google Scholar
B. Peral, J. L. San Millán, R. Castello, P. Moghetti, and H. F. Escobar-Morreale, “Comment: the methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1B) is associated with the polycystic ovary syndrome and hyperandrogenism,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3977–3983, 2002.
View at: Publisher Site | Google Scholar
M. Möhlig, J. Spranger, M. Osterhoff et al., “The polycystic ovary syndrome per se is not associated with increased chronic inflammation,” European Journal of Endocrinology, vol. 150, no. 4, pp. 525–532, 2004.
View at: Google Scholar
H. F. Escobar-Morreale, R. M. Calvo, G. Villuendas, J. Sancho, and J. L. San Millán, “Association of polymorphisms in the interleukin 6 receptor complex with obesity and hyperandrogenism,” Obesity Research, vol. 11, no. 8, pp. 987–996, 2003.
View at: Google Scholar
D. Seto-Young, M. Paliou, J. Schlosser et al., “Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6099–6105, 2005.
View at: Publisher Site | Google Scholar
D. Glintborg, R. K. Støving, C. Hagen et al., “Pioglitazone treatment increases spontaneous growth hormone (GH) secretion and stimulated GH levels in polycystic ovary syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 10, pp. 5605–5612, 2005.
View at: Publisher Site | Google Scholar
E. Jansen, J. S. E. Laven, H. B. R. Dommerholt et al., “Abnormal gene expression profiles in human ovaries from polycystic ovary syndrome patients,” Molecular Endocrinology, vol. 18, no. 12, pp. 3050–3063, 2004.
View at: Publisher Site | Google Scholar
J. R. Wood, V. l. Nelson-Degrave, E. Jansen, J. M. McAllister, S. Mosselman, and J. F. Strauss III, “Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects,” Physiological Genomics, vol. 20, pp. 233–243, 2005.
View at: Publisher Site | Google Scholar
J. M. Fernández-Real and W. Ricart, “Insulin resistance and chronic cardiovascular inflammatory syndrome,” Endocrine Reviews, vol. 24, no. 3, pp. 278–301, 2003.
View at: Google Scholar
E. Diamanti-Kandarakis, C. Piperi, J. Spina et al., “Polycystic ovary syndrome: the influence of environmental and genetic factors,” Hormones (Athens, Greece), vol. 5, no. 1, pp. 17–34, 2006.
View at: Google Scholar
G. S. Hotamisligil, P. Peraldi, A. Budavari, R. Ellis, M. F. White, and B. M. Spiegelman, “IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF- $α$ - and obesity-induced insulin resistance,” Science, vol. 271, no. 5249, pp. 665–668, 1996.
View at: Google Scholar
H. F. Escobar-Morreale, R. M. Calvo, J. Sancho, and J. L. San Millán, “TNF- $α$ and hyperandrogenism: a clinical, biochemical, and molecular genetic study,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 8, pp. 3761–3767, 2001.
View at: Publisher Site | Google Scholar
G. Villuendas, J. L. San Millán, J. Sancho, and H. F. Escobar-Morreale, “The -597 $G \to A$ and -174 $G \to C$ polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 1134–1141, 2002.
View at: Google Scholar
B. O. Yildiz, I. C. Haznedaroǧlu, S. Kirazli, and M. Bayraktar, “Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 8, pp. 3871–3875, 2002.
View at: Publisher Site | Google Scholar
P. Eriksson, B. Kallin, F. M. Van't Hooft, P. Bavenholm, and A. Hamsten, “Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 6, pp. 1851–1855, 1995.
View at: Google Scholar
E. Diamanti-Kandarakis, G. Palioniko, K. Alexandraki, A. Bergiele, T. Koutsouba, and M. Bartzis, “The prevalence of 4G5G polymorphism of plasminogen activator ihibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels,” European Journal of Endocrinology, vol. 150, no. 6, pp. 793–798, 2004.
View at: Publisher Site | Google Scholar
S. Nayak, P. A. Lee, and S. F. Witchel, “Variants of the type II 3 $β$ -hydroxysteroid dehydrogenase gene in children with premature pubic hair and hyperandrogenic adolescents,” Molecular Genetics and Metabolism, vol. 64, no. 3, pp. 184–192, 1998.
View at: Publisher Site | Google Scholar
N. Moghrabi, I. A. Hughes, A. Dunaif, and S. Andersson, “Deleterious missense mutations and silent polymorphism in the human 17 $β$ -hydroxysteroid dehydrogenase 3 gene (HSD17B3),” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2855–2860, 1998.
View at: Google Scholar
R. S. Legro, D. R. Muhleman, D. E. Comings, R. A. Lobo, and B. W. Kovacs, “A dopamine D3 receptor genotype is associated with hyperandrogenic chronic anovulation and resistant to ovulation induction with clomiphene citrate in female hispanics,” Fertility and Sterility, vol. 63, no. 4, pp. 779–784, 1995.
View at: Google Scholar
M. Kahsar-Miller, L. R. Boots, and R. Azziz, “Dopamine D3 receptor polymorphism is not associated with the polycystic ovary syndrome,” Fertility and Sterility, vol. 71, no. 3, pp. 436–438, 1999.
View at: Publisher Site | Google Scholar
S. P. Zhao, X. M. Tang, D. H. Shao, H. Y. Dai, and S. Z. Dai, “Association study between a polymorphism of aldosterone synthetase gene and the pathogenesis of polycystic ovary syndrome,” Zhonghua Fu Chan Ke Za Zhi, vol. 38, no. 2, pp. 94–97, 2003.
View at: Google Scholar
M. Rajkhowa, J. A. Talbot, P. W. Jones, and R. N. Clayton, “Polymorphism of glycogen synthetase gene in polycystic ovary syndrome,” Clinical Endocrinology, vol. 44, no. 1, pp. 85–90, 1996.
View at: Google Scholar
M. Urbanek, Y. Du, K. Silander et al., “Variation in resistin gene promoter not associated with polycystic ovary syndrome,” Diabetes, vol. 52, no. 1, pp. 214–217, 2003.
View at: Google Scholar
S. Heinonen, S. Korhonen, M. Hippelainen, M. Hiltunen, A. Mannermaa, and S. Saarikoski, “Apolipoprotein E alleles in women with polycystic ovary syndrome,” Fertility and Sterility, vol. 75, no. 5, pp. 878–880, 2001.
View at: Publisher Site | Google Scholar
R. Azziz, “PCOS: a diagnostic challenge,” Reproductive BioMedicine Online, vol. 8, no. 6, pp. 644–648, 2004.
View at: Google Scholar
D. Gordon and S. J. Finch, “Factors affecting statistical power in the detection of genetic association,” Journal of Clinical Investigation, vol. 115, no. 6, pp. 1408–1418, 2005.
View at: Publisher Site | Google Scholar
H. F. Escobar-Morreale, M. Luque-Ramírez, and J. L. San Millán, “The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome,” Endocrine Reviews, vol. 26, no. 2, pp. 251–282, 2005.
View at: Publisher Site | Google Scholar
M. Garg, M. Thamotharan, L. Rogers, S. Bassilian, W. N. P. Lee, and S. U. Devaskar, “Glucose metabolic adaptations in the intrauterine growth-restricted adult female rat offspring,” American Journal of Physiology - Endocrinology and Metabolism, vol. 290, no. 6, pp. E1218–E1226, 2006.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2007 Ugur Unluturk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

1251

Downloads

1766

Citations